Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
about
Antibiotic prophylaxis: different practice patterns within and outside the United StatesComparative safety and tolerability of anti-VEGF therapy in age-related macular degenerationEndophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive reviewAntibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-AnalysisImmediate Sequential Bilateral Pediatric Vitreoretinal Surgery: An International Multicenter Study.Endophthalmitis: state of the art.Emerging techniques for pathogen discovery in endophthalmitis.Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT)Incidence of Endophthalmitis after Intravitreal Bevacizumab using Aliquots Prepared On-site in 2 Operating Rooms in KuwaitComplications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications.Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues.Bacterial and Fungal Endophthalmitis.Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms.Vitreous hemorrhage as an early sign of acute bacterial endophthalmitis following intravitreal ranibizumab injection.The Finnish national guideline for diagnosis, treatment and follow-up of patients with wet age-related macular degeneration.Postoperative endophthalmitis incidence after intravitreal therapy: a comparison of two different preoperative antibiotic prophylaxis.Identification of Species in a Patient with Endophthalmitis following Penetrating Injury with Retained Intraocular Metallic Foreign BodyCausative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
P2860
Q26766557-3E92DAE1-2B39-4CCF-9D5D-971E9D29A46DQ26852289-579DBBBA-2947-4605-B677-FF221591A5CFQ28084070-157355F1-E30E-4208-954D-AC6656B1FA9AQ28276112-8EE8DDA5-74E9-4C18-8141-40A56C8A5ED6Q33924139-818DCAD2-DCE6-4C3B-8080-54EF122044AEQ34952098-8E0DACD3-3E28-4016-B52D-B89282E11CBCQ35586774-565A3118-5C17-4D2C-90B9-BED8FFCB4FF6Q35742777-5E91848A-8D66-4145-8E7E-425A4E942A1FQ36596479-46DEC24F-E8F0-47D9-86E2-D0052CCF57C7Q38261103-88701904-78E0-40AE-8B4C-6238320F008CQ38633532-91C6AE0A-BEC0-41E2-9BB8-F30FBDF5985DQ39207363-736E7D0F-2F68-482C-A69C-65732A0B88B4Q40116769-AAD2F7DE-A002-4CCD-A978-81DD6B62C002Q48339204-34DA81A6-E777-42A5-B180-552E98A3144AQ50903375-CC056AE0-E87F-427D-9E4A-CAB7D18FCFD3Q51537659-45C6ED64-EC70-4EA6-A2F1-6E1F6E7FBF48Q57821431-3A4F598C-65AB-4191-9A19-3F75B2EEAEBCQ58784488-5D0E7DA9-2791-4251-9354-4646189D0F35
P2860
Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Meta-analysis of infectious en ...... othelial growth factor agents.
@ast
Meta-analysis of infectious en ...... othelial growth factor agents.
@en
type
label
Meta-analysis of infectious en ...... othelial growth factor agents.
@ast
Meta-analysis of infectious en ...... othelial growth factor agents.
@en
prefLabel
Meta-analysis of infectious en ...... othelial growth factor agents.
@ast
Meta-analysis of infectious en ...... othelial growth factor agents.
@en
P2093
P1476
Meta-analysis of infectious en ...... othelial growth factor agents.
@en
P2093
Harry W Flynn
Ingrid U Scott
John B Fileta
P304
P356
10.3928/23258160-20140306-08
P577
2014-03-01T00:00:00Z